Categories
Brain Cancer

Biobank to help find new treatments for brain cancer | ABC News [Video]

The two cases inspired a group of friends and family to raise money for brain cancer research, through the Royal Hobart Hospital Research Foundation.Some of the funds raised will establish a brain cancer biobank in Tasmania to help progress medical research.Subscribe: http://ab.co/1svxLVE Read more here: https://ab.co/3I7jjlmABC News provides around the clock coverage of news events as they break in Australia and abroad, including the latest coronavirus pandemic updates. It’s news when you want it, from Australia’s most trusted news organisation.For more from ABC News, click here: https://ab.co/2kxYCZYWatch more ABC News content ad-free on iview: https://ab.co/2OB7Mk1Go deeper on our ABC News In-depth channel: https://ab.co/2lNeBn2Like ABC News on Facebook: http://facebook.com/abcnews.auFollow ABC News on Instagram: http://instagram.com/abcnews_auFollow ABC News on Twitter: http://twitter.com/abcnewsNote: In most cases, our captions are auto-generated.#ABCNews #ABCNewsAustralia

Categories
Blood Cancer

We are all Beautiful Bioreactors | Christopher Leidli | TEDxBreckenridge [Video]

The treatment of cancer, and other diseases, is being transformed by powerful new cellular therapies using immune cells from our own bodies. Cancer is personal—we all know someone afflicted with cancer. What if we could treat cancer differently? In this talk, Chris shares how recent scientific breakthroughs have led to advances in cell therapy treatments which will empower us to fight cancer and other diseases using our own immune cells and will help us take control of our healing journeys.Chris Leidli, MS, MBA, has worked at leading biotechnology companies, like Amgen, where he performed cancer research and development in pursuit of novel targeted therapies, biologics, and cell and gene therapies. He has graduate level training in molecular biology, physiology and cell biophysics from the University of Cincinnati College of Medicine and later went on to earn his MBA from the University of Southern California Marshall School of Business. This talk was given at a local TEDx event at TEDxBreckenridge in Breckenridge, CO, and was produced independently of the TED Conferences. Learn more at https://www.ted.com/tedx. Chris Leidli, MS, MBA, has worked at leading biotechnology companies, like Amgen, where he performed cancer research and development in pursuit of novel targeted therapies, biologics, and cell and gene therapies. He has graduate level training in molecular biology, physiology and cell biophysics from the University of Cincinnati College of Medicine and later went on to earn his MBA from the University of Southern California Marshall School of Business. Chris is the Founder of Boulder Biotech Launch Specialists LLC, a boutique consulting agency with a focus on helping biotechnology companies commercialize and launch innovative new products including cell and gene therapies. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx

Categories
Pediatric Cancer

Biobanking: how can we make it meet the needs of researchers? [Video]

In the final TRI Director’s Choice Seminar for 2021, our guest speakers and panellists put the spotlight on the field of biobanking in medical research. They share their experiences in obtaining and collecting biological and clinical data from human subjects to establish and maintain successful biobanks, along with the enablers and barriers they have encountered. We also asked them to share their big-picture learnings.MCs: Prof John Upham & Prof Maher GandhiSpeakers:A/Prof Andy Moore (Children’s Health Qld Tumour Biobank)Director of Research & Senior Staff Specialist, Paediatric Oncology, Children’s Health Queensland Hospital and Health ServiceA/Prof Glenda Gobe (Kidney Biobank)School of Biomedical Sciences, Faculty of Medicine, The University of QueenslandPanellistsProf Vicki Clifton (Queensland Family Cohort Study)NHMRC Senior Research Fellow; Mothers, Babies and Women’s Health Research Theme Program Leader; Pregnancy and Development Research Group Leader,Mater ResearchMs Rebecca Rogers (Breast cancer biobank)Pathology and Clinical Research Coordinator, Mater ResearchProfessor Gerald Holtmann (Gut microbiome biobank)Director of Gastroenterology & Hepatology, Princess Alexandra Hospital; Professor of Medicine & Director of Clinical Innovation, The University of Queensland

Categories
Brain Cancer

Insights on First Imaging Technology to detect Cancer with Imagion Biosystems [Video]

During the first half of 2021, Imagion has continued to make progress in relation to the Phase I Study of its novel MagSense® technology for the detection and staging of HER2 metastatic breast cancer. We speak with Bob Proulx, CEO of Imagion Biosystems about the first imaging technology to use targeted magnetic nanoparticles to tag and detect cancers. .#ImagionBiosystems #stagingofHER2metastaticbreastcancer #magsensetechnology #bobproulx #kalkinemediaKalkine TV is a one-stop solution to all the market-related nuances. The streaming platform offers in-depth and latest information on share market, commodities, crypto charter and economic developments. Kalkine TV leverages the expertise of in-house sector specialists, fundamental analysts and technical experts to touch base on hot trends driving the market charter and volatility. So, do tune in to Kalkine TV daily to catch live talk shows, market beats, and sector analysis.To get more updates about Australia, NZ, UK, Canada and US stock market news, investors education & insights, subscribe our channel at https://bit.ly/3cHKioyCheck out our media Website 👉 https://kalkinemedia.com/au Follow us and stay updated on the Go with the Market Charter 👇👇Facebook – https://www.facebook.com/kalkineau/ Twitter – https://twitter.com/kalkineau LinkedIn – https://www.linkedin.com/company/4829818